Publications by authors named "Russ A Kuker"

Claim this Profile
C
Characterization of Sinonasal Lesions on CT, MRI, and PET/CT.
Jiaqiong Wang, Russ A Kuker, Jian Q Michael Yu, Neelu Jain, Alexander M McKinney

Clin Nucl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 10% Rule in Sentinel Node Biopsy: Is Removal of All Threshold Nodes Necessary?
Jake Langlie, Nicholas DiStefano, Jaylou Velez-Torres, Carmen Gomez-Fernandez, Russ A Kuker

Otolaryngol Head Neck Surg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET/CT in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone Lymphoma.
Juan Pablo Alderuccio, Russ A Kuker, Eduardo Edelman Saul, Michele D Stanchina, Mark K Polar

Am J Hematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Learning-Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial.
Russ A Kuker, Juan P Alderuccio, Sunwoo Han, Mark K Polar, Tracy E Crane

JCO Clin Cancer Inform· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial.
Juan Pablo Alderuccio, Alvaro J Alencar, Jonathan H Schatz, Russ A Kuker, Georgios Pongas

Lancet Haematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calciphylaxis in a 30-Year-Old Woman With Alcoholic Cirrhosis: A Case Report.
Adrian Parra, Russ A Kuker

Cureus· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging Programmatic Collaboration for a Radiopharmaceutical Clinic.
Charles A Kunos, Molly E Martin, Michalis F Georgiou, Russ A Kuker, Aman Chauhan

Cancers (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial.
Juan Pablo Alderuccio, Isildinha M Reis, Mehdi Hamadani, Muthiah Nachiappan, Salman Leslom, Russ A Kuker

Clin Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Artificial Intelligence System for Optimizing Radioactive Iodine Therapy Dosimetry.
Michalis F Georgiou, Joshua A Nielsen, Rommel Chiriboga, Russ A Kuker

J Clin Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Utility of PET/CT for the Diagnosis of Periosteal Chondrosarcoma in a Patient With Maffucci's Syndrome.
Atishay Jain, James Cassuto, Efrosyni Sfakianaki, Russ A Kuker, Hamza Alizai

Cureus· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative PET-based biomarkers in lymphoma: getting ready for primetime.
Juan Pablo Alderuccio, Russ A Kuker, Fei Yang, Craig H Moskowitz

Nat Rev Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell Lymphoma.
Russ A Kuker, David Lehmkuhl, Deukwoo Kwon, Weizhao Zhao, Izidore S Lossos

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of presalvage metabolic tumor volume in patients with relapsed/refractory diffuse large B-cell lymphoma.
Juan Pablo Alderuccio, Russ A Kuker, Priscila Barreto-Coelho, Bianca M Martinez, Feng Miao

Leuk Lymphoma· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung shunt fraction calculation using Tc-MAA SPECT/CT imaging for Y microsphere selective internal radiation therapy of liver tumors.
Mike F Georgiou, Russ A Kuker, Matthew T Studenski, Preeti P Ahlman, Megan Witte

EJNMMI Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False Positive Findings on I-131 WBS and SPECT/CT in Patients with History of Thyroid Cancer: Case Series.
Zeina C Hannoush, Juan D Palacios, Russ A Kuker, Sabina Casula

Case Rep Endocrinol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(124)I PET/CT in Patients with Differentiated Thyroid Cancer: Clinical and Quantitative Image Analysis.
Seza A Gulec, Russ A Kuker, Mohammed Goryawala, Carlos Fernandez, Rudolfo Perez

Thyroid· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism.
Michalis F Georgiou, Ati Gonenc, Drenna Waldrop-Valverde, Russ A Kuker, Shabbir H Ezuddin

J Nucl Med· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of FDG-PET/CT imaging protocol for evaluation of patients with primary and metastatic liver disease.
Russ A Kuker, Geraldine Mesoloras, Seza A Gulec

Int Semin Surg Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis